US20090304682A1 - Multiple-variable dose regimen for treating TNFa-related disorders - Google Patents

Multiple-variable dose regimen for treating TNFa-related disorders Download PDF

Info

Publication number
US20090304682A1
US20090304682A1 US12/008,064 US806408A US2009304682A1 US 20090304682 A1 US20090304682 A1 US 20090304682A1 US 806408 A US806408 A US 806408A US 2009304682 A1 US2009304682 A1 US 2009304682A1
Authority
US
United States
Prior art keywords
tnfα
antibody
dose
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/008,064
Inventor
Rebecca S. Hoffman
Elliot K. Chartash
Lori K. Taylor
George R. Granneman
Philip Yan
Susan K. Paulson
Joanna Z. Peng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Biotechnology Ltd
Original Assignee
AbbVie Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US56113904P priority Critical
Priority to US56171004P priority
Priority to US56910004P priority
Priority to US11/104,117 priority patent/US8889136B2/en
Priority to US80158406P priority
Priority to US84996706P priority
Priority to US91817407P priority
Priority to US80458707A priority
Priority to US12/008,064 priority patent/US20090304682A1/en
Application filed by AbbVie Biotechnology Ltd filed Critical AbbVie Biotechnology Ltd
Assigned to ABBOTT BIOTECHNOLOGY LTD reassignment ABBOTT BIOTECHNOLOGY LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHARTASH, ELLIOT K.
Assigned to ABBOTT BIOTECHNOLOGY LTD reassignment ABBOTT BIOTECHNOLOGY LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TAYLOR, LORI K.
Assigned to ABBOTT BIOTECHNOLOGY LTD reassignment ABBOTT BIOTECHNOLOGY LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: YAN, PHILIP, HOFFMAN, REBECCA S., PAULSON, SUSAN K., PENG, JOANNA Z.
Assigned to ABBOTT BIOTECHNOLOGY LTD reassignment ABBOTT BIOTECHNOLOGY LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRANNEMAN, GEORGE R.
Publication of US20090304682A1 publication Critical patent/US20090304682A1/en
Assigned to ABBVIE BIOTECHNOLOGY LTD. reassignment ABBVIE BIOTECHNOLOGY LTD. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ABBOTT BIOTECHNOLOGY LTD.
Application status is Abandoned legal-status Critical

Links